Replies to post #199550 on Anavex Life Sciences Corp (AVXL)

[Gator328]

I'm fine with losing 100% of my investment in AVXl. Obviously I would prefer not to but I assume the risk of investing in any company, especially start-up biotech trying to cure the one of the most elusive diseases.

What Missling is doing is going all-in with pocket Qs. It's a solid hand, but not waiting for the flop. Its risky, and not a move that I particularly agree with for the obvious reason that it's still an easily defeated hand.

The other issue is that going at it alone is going to cost a LOT more than $250M. So this offering won't be sufficient to properly bring the drug to market without a partner.

So the way I see it, the $250M is the tip of the iceberg. And the 100M A/S is going to be increased.

If he's going to have to dilute massively anyway, may as well partner and get the added benefit of expertise, manufacturing labs, and a boost in reputation to ward off future short attacks.